The recommendations emphasize the importance of treating low-density lipoprotein cholesterol (LDL-C) in some individuals to lower goals than previously endorsed and support the measurement of coronary artery calcium scores and inflammatory markers

Coming soon – AACE's updated recommendations will be presented during the live digital AACE Innovation in Cardiometabolic Clinical Conference October 2-4, 2020. Sign up now – you won't want to miss this!